Low doses of digoxin, captopril, metoprolol and spironolactone in combination in treatment of elderly cardiac insufficiency

Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2002, Vol. 7 ›› Issue (5): 463-464.

Previous Articles Next Articles

Low doses of digoxin, captopril, metoprolol and spironolactone in combination in treatment of elderly cardiac insufficiency

LI Xiao-Guang, CHEN Xue-Wen

Second Department of InternalMedicine, Shanxi Provincial Second People's Hospital, Xi'an 710005

Received:2002-03-04 Revised:2002-07-20 Published:2020-11-26

Abstract

CLC Number:

LI Xiao-Guang, CHEN Xue-Wen. Low doses of digoxin, captopril, metoprolol and spironolactone in combination in treatment of elderly cardiac insufficiency[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(5): 463-464.

[1]	CHENG Kuan. New progress in research and application of fenneridone [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 450-456.
[2]	JIANG Hui，MIAO Miao，XU Wenke. Effects of ABCB13435C/T and 2677T/G gene polymorphisms on serum concentration of digoxin in Han population [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 188-191.
[3]	OUYANG Cang-hong, XIE Juan. Study on the relationship between the MDR1 and CYP3A genetic polymorphisms and serum digoxin concentration in 111 patients with chronic heart failure [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(3): 291-296.
[4]	ZHU Hong-xia, WANG Xue-feng, XU Qian. Clinical comparative study on nifedipine sustained release tablets combined separately with enalapril maleate tablets and metoprolol tartrate tablets in treating high-risk hypertensive patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1167-1170.
[5]	YANG Yan-lang^1,2, ZOU He-qun¹, ZHANG Dao-you², WANG Yu-wei², LI Fan-xia², GAO Chao-qing², XU Hai-hong², CHENG Xiao-mei². Renal tubular protection effect of combining benazepril and spironolactone in adriamycin-induced nephritic rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(4): 381-386.
[6]	XIONG Dan, XIONG Yu-qing. Polymorphism of CYP2D6 gene and the influence on the metabolism of metoprolol [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(9): 1059-1064.
[7]	XU Cheng-hua, YANG Yu-wen, CAO Heng. Effectes of β₁-adrenergic receptor and CYP2D6 gene polymorphism on metoprolol antihypertension therapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(12): 1414-1418.
[8]	LI Yue-chun, CHEN Peng, GE Li-sha, REN Jiang-hua. Effects of carvedilol on the activities of IFN-γand IL-12 and oxygen free radical in murine model with coxsackievirus B3-induced viral myocarditis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(10): 1101-1105.
[9]	WANG Xing, WANG De-guo, KE Yong-sheng, TANG Zheng-guo, YANG Yu-wen, WANG An-cai. Effects of antidigoxin antiserum on expression of NOSs in ischemiareperfusion myocardium of rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(7): 753-757.
[10]	LI Qin, WANG Rui, GUO Ya, PEI Fei. Influence of CYP2D6 genetic polymorphism on pharmacokinetics of metoprolol in Chinese population [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(7): 796-802.
[11]	JIA Yuan-wei, XIE Hai-tang, WANG Guang-ji. Development and validation of a liquid chromatographic electrospray ionization mass spectrometric method for the determination of digoxin in human plasma [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(12): 1422-1425.
[12]	XIONG Hui, XIONG Lei, SU Dan, XIN Hua-wen, WU Xiao-chun, LI Qing, LI Gao. Effects of five drugs including ciclosporin and nifedipine which were usually used in patients with kidney transplantation on erythrocyte thiopurinemethyltransferase activity [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(12): 1411-1414.
[13]	LIU Jie, LIU Zhao-qian, LIU Ying-zi, TAN Zhi-rong, HU Dong-li, LI Zhi, WANG Dan, ZHANG Wei, ZHOU Hong-hao. Effects ofβ₁-adrenergic receptor and CYP2D6 genetic polymorphism on metoprolol pharmacokinetics and pharmacodynamics in antihypertension therapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(10): 1130-1137.
[14]	WANG Jing, FU Liang-qing, GUAN Yong-biao<, FANG Yi<, LIU Ze-yuan. Bioequivalence of Metoprolol Tartrate Tablets in healthy volunteers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(9): 1043-1047.
[15]	LUO Bi-hui, ZENG Zhao-hua, WANG Xin-liang, HE Zhao-chu, SU Chen-jian. Different role of aldosterone in cardiac hypertrophy and cardiac fibrosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(12): 1397-1402.

Low doses of digoxin, captopril, metoprolol and spironolactone in combination in treatment of elderly cardiac insufficiency

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments